Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis

Gastroenterology

Volumn 153, Issue 1, 2017, Pages 53-55.e7

  Nasr, Patrik ^a   Forsgren, Mikael F ^a   Ignatova, Simone ^a   Dahlström, Nils ^a   Cedersund, Gunnar ^a   Leinhard, Olof Dahlqvist ^a   Norén, Bengt ^a   Ekstedt, Mattias ^a   Lundberg, Peter ^a   Kechagias, Stergios ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diagnostic Tests; NASH; Nonalcoholic Fatty Liver Disease

Indexed keywords

LIVER ENZYME; TRIACYLGLYCEROL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FAT CONTENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON DENSITY FAT FRACTION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; STEREOLOGIC POINT COUNTING; STEREOMETRY; AGED; BIOPSY; LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PATHOLOGY;

ADIPOSITY; ADULT; AGED; BIOPSY; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 85020887860     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.03.005     Document Type: Article

References (28)

1. Kleiner, D.E., et al. Hepatology 41 (2005), 1313–1321.
2. Franzén, L.E., et al. Mod Pathol 18 (2005), 912–916.
3. Reeder, S.B., et al. J Magn Reson Imaging 34 (2011), 729–749.
4. Bannas, P., Kramer, H., et al. Hepatology 62 (2015), 1444–1455.
5. Szczepaniak, L.S., et al. Am J Physiol Endocrinol Metab 288 (2005), E462–E468.
6. Tang, A., et al. Radiology 267 (2013), 422–431.
7. Tang, A., et al. Radiology 274 (2015), 416–425.
8. EASL-EASD-EASO. J Hepatol 64 (2016), 1388–1402.
9. Ekstedt, M., Hagström, H., et al. Hepatology 61 (2015), 1547–1554.
10. Angulo, P., et al. Gastroenterology 149 (2015), 389–397.
11. Rehm, J.L., et al. Eur Radiol 25 (2015), 2921–2930.
12. Bush, K., et al. Arch Intern Med 158 (1998), 1789–1795.
13. World Health Organization, International Diabetes Federation. Geneva, Switzerland: 2006.
14. Naressi, A., et al. MAGMA 12 (2001), 141–152.
15. Vanhamme, L., et al. J Magn Reson 129 (1997), 35–43.
16. Hamilton, G., et al. NMR Biomed 24 (2011), 784–790.
17. Thomsen, C., et al. Magn Reson Imaging 12 (1994), 487–495.
18. Lee, S.S., et al. J Magn Reson Imaging 33 (2011), 1390–1398.
19. Longo, R., et al. J Magn Reson Imaging 5 (1995), 281–285.
20. Kleiner, D.E., et al. Hepatology 41 (2005), 1313–1321.
21. Franzén, L.E., et al. Mod Pathol 18 (2005), 912–916.
22. Turlin, B., et al. Semin Diagn Pathol 15 (1998), 237–245.
23. Norén, B., et al. Eur J Radiol 66 (2008), 313–320.
24. El-Badry, A.M., et al. Ann Surg 250 (2009), 691–697.
25. Reeder, S.B., et al. J Magn Reson Imaging 36 (2012), 1011–1014.
26. Bannas, P., Kramer, H., et al. Hepatology 62 (2015), 1444–1455.
27. Hamilton, G., et al. J Magn Reson Imaging 30 (2009), 145–152.
28. Ratziu, V., et al. Gastroenterology 128 (2005), 1898–1906.